Angeles Wealth Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$305K Buy
2,587
+555
+27% +$77.5K 0.02% 317
2025
Q4
$333K Buy
2,032
+125
+7% +$19.6K 0.02% 277
2025
Q3
$255K Buy
1,907
+225
+13% +$27.3K 0.02% 286
2025
Q2
$209K Buy
+1,682
New +$214K 0.01% 323
2025
Q1
Sell
-1,526
Closed -$220K 382
2024
Q4
$220K Buy
+1,526
New +$219K 0.02% 275

Other funds holding RGEN

Angeles Wealth Management's RGEN Position: Q1 2026 in Review

Angeles Wealth Management increased its Repligen (RGEN) stake by 27% in Q1 2026, buying an estimated $77.5K and bringing the position to 2,587 shares worth $305K. The position accounts for 0.02% of the portfolio, ranked #317.

Angeles Wealth Management first reported a position in RGEN in Q4 2024 and has held it in 5 quarters since. The position peaked at $333K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Angeles Wealth Management held 2,587 shares of Repligen worth $305K as of Q1 2026.
  • Angeles Wealth Management bought 555 Repligen shares in Q1 2026, an estimated $77.5K.
  • Repligen made up 0.02% of Angeles Wealth Management's portfolio in Q1 2026, its #317 holding.
  • Angeles Wealth Management first reported a position in Repligen in Q4 2024 and has held it in 5 quarters since.
  • Angeles Wealth Management's Repligen position peaked at $333K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Angeles Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.